1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:733478 6480464 o, p'-DDT results in increased expression of OLFM1 mRNA CTD PMID:19371625 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of OLFM1 mRNA CTD PMID:12832660 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO RGD:733478 6480464 14-deoxy-11, 12-didehydroandrographolide results in decreased expression of OLFM1 mRNA CTD PMID:22101062 17alpha-ethynylestradiol increases expression ISO RGD:733479 6480464 Ethinyl Estradiol results in increased expression of OLFM1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:733479 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OLFM1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of OLFM1 mRNA CTD PMID:12075121 17alpha-ethynylestradiol affects expression ISO RGD:733479 6480464 Ethinyl Estradiol affects the expression of OLFM1 mRNA CTD PMID:17555576 17beta-estradiol affects expression ISO RGD:733478 6480464 Estradiol affects the expression of OLFM1 mRNA CTD PMID:14699072 17beta-estradiol increases expression ISO RGD:733478 6480464 Estradiol results in increased expression of OLFM1 mRNA CTD PMID:16474171 more ... 17beta-estradiol decreases expression ISO RGD:733478 6480464 Estradiol results in decreased expression of OLFM1 protein CTD PMID:18191855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733479 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OLFM1 mRNA, AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of OLFM1 mRNA] CTD PMID:15034205 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733479 6480464 Tetrachlorodibenzodioxin results in decreased expression of OLFM1 mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733479 6480464 Tetrachlorodibenzodioxin results in increased expression of OLFM1 mRNA CTD PMID:19933214 2-acetamidofluorene increases expression ISO RGD:733479 6480464 2-Acetylaminofluorene results in increased expression of OLFM1 mRNA CTD PMID:20713471 3-methylcholanthrene increases expression ISO RGD:733479 6480464 Methylcholanthrene results in increased expression of OLFM1 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide decreases expression ISO RGD:733479 6480464 Fenretinide results in decreased expression of OLFM1 mRNA CTD PMID:28973697 5-fluorouracil increases expression ISO RGD:733478 6480464 Fluorouracil results in increased expression of OLFM1 protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:733478 6480464 OLFM1 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 afimoxifene multiple interactions ISO RGD:733478 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of OLFM1 mRNA] CTD PMID:21233418 aflatoxin B1 decreases expression ISO RGD:733478 6480464 Aflatoxin B1 results in decreased expression of OLFM1 mRNA CTD PMID:31555880 all-trans-retinoic acid decreases expression ISO RGD:733478 6480464 Tretinoin results in decreased expression of OLFM1 mRNA CTD PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of OLFM1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:733478 6480464 Antirheumatic Agents results in decreased expression of OLFM1 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:733478 6480464 Arsenic affects the methylation of OLFM1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:733478 6480464 Arsenic affects the methylation of OLFM1 gene CTD PMID:25304211 benzo[a]pyrene multiple interactions ISO RGD:733479 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of OLFM1 mRNA] CTD PMID:15034205 benzo[a]pyrene decreases expression ISO RGD:733478 6480464 Benzo(a)pyrene results in decreased expression of OLFM1 mRNA CTD PMID:31555880 benzo[a]pyrene increases expression ISO RGD:733479 6480464 Benzo(a)pyrene results in increased expression of OLFM1 mRNA CTD PMID:15034205 , PMID:20713471 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:733478 6480464 Diethylhexyl Phthalate results in decreased expression of OLFM1 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA CTD PMID:31199487 bisphenol A increases expression ISO RGD:733478 6480464 bisphenol A results in increased expression of OLFM1 mRNA CTD PMID:16474171 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of OLFM1 mRNA CTD PMID:25181051 butanal increases expression ISO RGD:733478 6480464 butyraldehyde results in increased expression of OLFM1 mRNA CTD PMID:26079696 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA CTD PMID:31199487 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of OLFM1 promoter CTD PMID:22457795 carbon nanotube increases expression ISO RGD:733479 6480464 Nanotubes, Carbon analog results in increased expression of OLFM1 mRNA CTD PMID:25554681 cisplatin multiple interactions ISO RGD:733478 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of OLFM1 mRNA CTD PMID:27392435 clomiphene decreases expression ISO RGD:733478 6480464 Clomiphene results in decreased expression of OLFM1 mRNA CTD PMID:26865669 cocaine affects expression EXP 6480464 Cocaine affects the expression of OLFM1 mRNA CTD PMID:20187946 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of OLFM1 mRNA, Copper results in increased expression of OLFM1 mRNA CTD PMID:22465980 , PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of OLFM1 mRNA, Copper results in increased expression of OLFM1 mRNA CTD PMID:22465980 , PMID:26033743 coumestrol increases expression ISO RGD:733478 6480464 Coumestrol results in increased expression of OLFM1 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:733478 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of OLFM1 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA CTD PMID:31199487 dibutyl phthalate decreases expression ISO RGD:733479 6480464 Dibutyl Phthalate results in decreased expression of OLFM1 mRNA CTD PMID:21266533 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA CTD PMID:31199487 diethylstilbestrol increases expression ISO RGD:733478 6480464 Diethylstilbestrol results in increased expression of OLFM1 mRNA CTD PMID:19371625 , PMID:26865669 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA CTD PMID:31199487 dorsomorphin multiple interactions ISO RGD:733478 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733478 6480464 Doxorubicin results in decreased expression of OLFM1 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:733478 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OLFM1 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:733478 6480464 entinostat results in increased expression of OLFM1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:733478 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFM1 mRNA CTD PMID:27188386 estrone increases expression ISO RGD:733478 6480464 Estrone results in increased expression of OLFM1 mRNA CTD PMID:26865669 ethanol affects expression ISO RGD:733479 6480464 Ethanol affects the expression of OLFM1 mRNA CTD PMID:30319688 fulvestrant decreases expression ISO RGD:733478 6480464 fulvestrant results in decreased expression of OLFM1 mRNA CTD PMID:26865669 genistein increases expression ISO RGD:733478 6480464 Genistein results in increased expression of OLFM1 mRNA CTD PMID:16474171 more ... gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of OLFM1 mRNA CTD PMID:22061828 hexestrol increases expression ISO RGD:733478 6480464 Hexestrol results in increased expression of OLFM1 mRNA CTD PMID:26865669 manganese atom increases expression ISO RGD:733478 6480464 Manganese results in increased expression of OLFM1 mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:733478 6480464 Manganese results in increased expression of OLFM1 mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:733478 6480464 manganese chloride results in increased expression of OLFM1 mRNA CTD PMID:17175027 mestranol increases expression ISO RGD:733478 6480464 Mestranol results in increased expression of OLFM1 mRNA CTD PMID:26865669 methapyrilene decreases expression ISO RGD:733478 6480464 Methapyrilene results in decreased expression of OLFM1 mRNA CTD PMID:31555880 methotrexate decreases expression ISO RGD:733478 6480464 Methotrexate results in decreased expression of OLFM1 mRNA CTD PMID:24449571 methylmercury chloride increases expression ISO RGD:733478 6480464 methylmercuric chloride results in increased expression of OLFM1 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium increases expression ISO RGD:733478 6480464 1-Methyl-4-phenylpyridinium results in increased expression of OLFM1 mRNA CTD PMID:24810058 N-nitrosodiethylamine increases expression ISO RGD:733479 6480464 Diethylnitrosamine results in increased expression of OLFM1 mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions ISO RGD:733479 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of OLFM1 mRNA] CTD PMID:17942915 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of OLFM1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of OLFM1 mRNA CTD PMID:25729387 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of OLFM1 mRNA CTD PMID:30723492 phenobarbital affects expression ISO RGD:733479 6480464 Phenobarbital affects the expression of OLFM1 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:733478 6480464 Phenylmercuric Acetate results in decreased expression of OLFM1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733478 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OLFM1 mRNA CTD PMID:27188386 progesterone decreases expression ISO RGD:733478 6480464 Progesterone results in decreased expression of OLFM1 mRNA CTD PMID:18037150 raloxifene decreases expression ISO RGD:733478 6480464 Raloxifene Hydrochloride results in decreased expression of OLFM1 mRNA CTD PMID:26865669 resveratrol decreases expression ISO RGD:733478 6480464 resveratrol results in decreased expression of OLFM1 mRNA CTD PMID:19371625 resveratrol multiple interactions ISO RGD:733478 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of OLFM1 mRNA CTD PMID:19167446 rotenone affects expression ISO RGD:733478 6480464 Rotenone affects the expression of OLFM1 mRNA CTD PMID:29428530 SB 431542 multiple interactions ISO RGD:733478 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:733478 6480464 Silicon Dioxide analog results in decreased expression of OLFM1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:733478 6480464 Silicon Dioxide analog results in increased expression of OLFM1 mRNA CTD PMID:23806026 sodium arsenite affects methylation ISO RGD:733478 6480464 sodium arsenite affects the methylation of OLFM1 gene CTD PMID:28589171 sodium arsenite decreases expression ISO RGD:733478 6480464 sodium arsenite results in decreased expression of OLFM1 mRNA CTD PMID:29301061 sunitinib decreases expression ISO RGD:733478 6480464 Sunitinib results in decreased expression of OLFM1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:733479 6480464 Tamoxifen affects the expression of OLFM1 mRNA CTD PMID:17555576 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of OLFM1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of OLFM1 mRNA CTD PMID:25729387 triclosan increases expression ISO RGD:733478 6480464 Triclosan results in increased expression of OLFM1 mRNA CTD PMID:30510588 undecane increases expression EXP 6480464 undecane results in increased expression of OLFM1 protein CTD PMID:17337753 valproic acid affects expression ISO RGD:733479 6480464 Valproic Acid affects the expression of OLFM1 mRNA CTD PMID:17963808 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of OLFM1 mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:733478 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFM1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733478 6480464 Valproic Acid results in increased expression of OLFM1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:733478 6480464 Valproic Acid affects the expression of OLFM1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:733478 6480464 Valproic Acid results in decreased expression of OLFM1 mRNA CTD PMID:23527032 vorinostat decreases expression ISO RGD:733478 6480464 vorinostat results in decreased expression of OLFM1 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:733478 6480464 vorinostat results in increased expression of OLFM1 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:733478 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFM1 mRNA CTD PMID:27188386 zearalenone increases expression ISO RGD:733478 6480464 Zearalenone results in increased expression of OLFM1 mRNA CTD PMID:19371625
Biological Process atrioventricular valve formation ISS UniProtKB:Q9IAK4 1600115 GO_REF:0000024 AgBase GO_REF:0000024 cardiac epithelial to mesenchymal transition ISS UniProtKB:Q9IAK4 1600115 GO_REF:0000024 AgBase GO_REF:0000024 negative regulation of amyloid-beta formation ISO RGD:733479 1624291 (MGI:MGI:5444053, PMID:22992957) RGD MGI:MGI:5444053 , PMID:22992957 negative regulation of gene expression ISS UniProtKB:Q9IAK4 1600115 GO_REF:0000024 AgBase GO_REF:0000024 negative regulation of neuron migration ISO RGD:733479 1624291 (MGI:MGI:5444053, PMID:22992957) RGD MGI:MGI:5444053 , PMID:22992957 neuronal signal transduction ISO RGD:733479 1624291 (MGI:MGI:5688832, PMID:22923615) RGD MGI:MGI:5688832 , PMID:22923615 neuronal signal transduction ISS UniProtKB:O88998 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of apoptotic process ISO RGD:733478 1624291 (PMID:16751333) RGD PMID:16751333 positive regulation of apoptotic process ISS UniProtKB:Q99784 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of epithelial to mesenchymal transition ISS UniProtKB:Q9IAK4 1600115 GO_REF:0000024 AgBase GO_REF:0000024 positive regulation of gene expression ISS UniProtKB:Q9IAK4 1600115 GO_REF:0000024 AgBase GO_REF:0000024 regulation of amyloid-beta formation ISO RGD:733479 1624291 (MGI:MGI:5444053, PMID:22992957) RGD MGI:MGI:5444053 , PMID:22992957 regulation of axon extension ISO RGD:733479 1624291 (MGI:MGI:5688832, PMID:22923615) RGD MGI:MGI:5688832 , PMID:22923615 regulation of axon extension ISS UniProtKB:O88998 1600115 GO_REF:0000024 UniProt GO_REF:0000024 Cellular Component AMPA glutamate receptor complex ISO RGD:733479 1624291 (MGI:MGI:5440375, PMID:22632720) RGD MGI:MGI:5440375 , PMID:22632720 axon ISO RGD:733479 1624291 (MGI:MGI:5688832, PMID:22923615) RGD MGI:MGI:5688832 , PMID:22923615 axon ISS UniProtKB:O88998 1600115 GO_REF:0000024 UniProt GO_REF:0000024 axonal growth cone ISO RGD:733479 1624291 (MGI:MGI:5688832, PMID:22923615) RGD MGI:MGI:5688832 , PMID:22923615 axonal growth cone ISS UniProtKB:O88998 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell ISS UniProtKB:Q9IAK4 1600115 GO_REF:0000024 AgBase GO_REF:0000024 cell junction IEA UniProtKB-KW:KW-0965 1600115 GO_REF:0000037 UniProt GO_REF:0000037 endoplasmic reticulum ISO RGD:733479 1624291 (MGI:MGI:5688832, PMID:22923615) RGD MGI:MGI:5688832 , PMID:22923615 endoplasmic reticulum ISS UniProtKB:O88998 1600115 GO_REF:0000024 UniProt GO_REF:0000024 extracellular space ISO RGD:733479 1624291 (MGI:MGI:3611587 more ... RGD MGI:MGI:3611587 more ... extracellular space ISS UniProtKB:O88998 1600115 GO_REF:0000024 UniProt GO_REF:0000024 extrinsic component of synaptic membrane ISO RGD:733479 1624291 (MGI:MGI:5616036, PMID:25218043) RGD MGI:MGI:5616036 , PMID:25218043 glutamatergic synapse ISO RGD:733479 1624291 (MGI:MGI:5616036, PMID:25218043) RGD MGI:MGI:5616036 , PMID:25218043 neuronal cell body ISO RGD:733479 1624291 (MGI:MGI:5688832, PMID:22923615) RGD MGI:MGI:5688832 , PMID:22923615 neuronal cell body ISS UniProtKB:O88998 1600115 GO_REF:0000024 UniProt GO_REF:0000024 perikaryon IEA UniProtKB-SubCell:SL-0197 1600115 GO_REF:0000039 UniProt GO_REF:0000039 synaptic membrane ISO RGD:733479 1624291 (MGI:MGI:5616036, PMID:25218043) RGD MGI:MGI:5616036 , PMID:25218043 Molecular Function amyloid-beta binding ISO RGD:733479 1624291 (MGI:MGI:5444053, PMID:22992957) RGD MGI:MGI:5444053 , PMID:22992957 identical protein binding ISO RGD:733479 1624291 UniProtKB:O88998 (MGI:MGI:3611587 , PMID:15927402) RGD MGI:MGI:3611587 , PMID:15927402 protein binding ISO RGD:733479 1624291 UniProtKB:O88998-3 more ... RGD MGI:MGI:3611587 , PMID:15927402 protein binding ISO RGD:733478 1624291 UniProtKB:Q9NRI5 (PMID:17043677), (PMID:31413325) RGD PMID:17043677 , PMID:31413325
Gene-Chemical Interaction Annotations
